415 related articles for article (PubMed ID: 9486679)
1. Treatment of genital warts with an immune-response modifier (imiquimod).
Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
[TBL] [Abstract][Full Text] [Related]
2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
[TBL] [Abstract][Full Text] [Related]
4. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod in clinical practice.
Edwards L
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Sauder DN; Skinner RB; Fox TL; Owens ML
Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
[TBL] [Abstract][Full Text] [Related]
8. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
[TBL] [Abstract][Full Text] [Related]
9. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
13. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
[TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod for the treatment of genital warts: a quantitative systematic review.
Moore RA; Edwards JE; Hopwood J; Hicks D
BMC Infect Dis; 2001; 1():3. PubMed ID: 11401728
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
20. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]